Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
acyl-CoA thioesterase 12 | 0.805 | 0.192 | 2.7E-14 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 1989 | 1989 | ||||||||
|
adenine phosphoribosyltransferase | 0.423 | 0.846 | 5.5E-13 |
|
disease | 0.210 | None | 1.000 | 1 | 0 | 1984 | 2019 | ||||||||
|
AKT serine/threonine kinase 2 | 0.474 | 0.769 | 0.64 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
aldo-keto reductase family 1 member B | 0.491 | 0.885 | 2.0E-05 |
|
disease | 0.240 | None | 0.800 | 1 | 0 | 1998 | 2017 | ||||||||
|
aldolase, fructose-bisphosphate C | 0.780 | 0.231 | 9.2E-02 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 1987 | 1987 | ||||||||
|
alpha-2-macroglobulin | 0.529 | 0.769 | 4.5E-11 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2004 | 2004 | ||||||||
|
asparagine synthetase (glutamine-hydrolyzing) | 0.595 | 0.692 | 9.4E-06 |
|
disease | 0.510 | None | 1.000 | 1 | 0 | 1976 | 2019 | ||||||||
|
ATP binding cassette subfamily A member 1 | 0.467 | 0.846 | 1.5E-13 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
ATP binding cassette subfamily B member 1 | 0.344 | 0.885 | 1.3E-05 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 1993 | 2020 | ||||||||
|
ATP binding cassette subfamily C member 3 | 0.517 | 0.769 | 1.2E-26 |
|
disease | 0.210 | None | 1.000 | 1 | 0 | 2004 | 2015 | ||||||||
|
C-terminal Src kinase | 0.606 | 0.692 | 1.00 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 1999 | 1999 | ||||||||
|
cadherin 1 | 0.401 | 0.808 | 0.15 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
calpain 3 | 0.564 | 0.615 | 3.6E-19 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2000 | 2000 | ||||||||
|
carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase | 0.482 | 0.846 | 1.00 |
|
disease | 0.200 | None | 1.000 | 2 | 0 | 1987 | 1989 | ||||||||
|
caspase 3 | 0.351 | 0.923 | 0.10 |
|
disease | 0.270 | None | 1.000 | 1 | 0 | 2007 | 2018 | ||||||||
|
caspase 8 | 0.404 | 0.923 | 3.7E-06 |
|
disease | 0.220 | None | 1.000 | 1 | 0 | 2015 | 2018 | ||||||||
|
caspase 9 | 0.458 | 0.808 | 7.4E-06 |
|
disease | 0.210 | None | 1.000 | 1 | 0 | 2018 | 2019 | ||||||||
|
cathepsin B | 0.457 | 0.846 | 5.9E-11 |
|
disease | 0.210 | None | 1.000 | 1 | 0 | 2005 | 2017 | ||||||||
|
cathepsin L | 0.488 | 0.846 | 8.0E-03 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
cell adhesion molecule 1 | 0.491 | 0.769 | 0.66 |
|
disease | 0.230 | None | 1.000 | 1 | 0 | 2007 | 2019 | ||||||||
|
coactivator associated arginine methyltransferase 1 | 0.601 | 0.692 | 1.00 |
|
disease | 0.220 | None | 1.000 | 1 | 0 | 2013 | 2019 | ||||||||
|
collagen type XVIII alpha 1 chain | 0.449 | 0.808 | 1.7E-10 |
|
disease | 0.240 | None | 1.000 | 1 | 0 | 2004 | 2011 | ||||||||
|
complement C3 | 0.445 | 0.885 | 0.90 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
cyclin dependent kinase 1 | 0.482 | 0.808 | 0.99 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
disease | 0.590 | None | 1.000 | 3 | 0 | 1996 | 2019 |